Arca
Skip to content
Tools
Tools

dermaPACE System

Extracorporeal Shock Wave Device For Treatment Of Diabetic Foot Ulcers. De Novo DEN160037, from Sanuwave, Inc. (Alpharetta, GA). Product code PZL, class 2.

As of Nov 20, 2026, DEN160037 is an FDA De Novo held by Sanuwave, Inc., granted on Dec 28, 2017 after 521 days, with no recalls tied to it in FDA's recall database.

  • Review time: 521 days
  • Recalls: 0
  • Cited as a predicate by: 2 devices

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The SANUWAVE dermaPACE System is indicated to provide acoustic pressure shockwaves in the treatment of chronic, full-thickness diabetic foot ulcers with wound areas measuring no larger than 16 cm2, which extend through the epidermis, dermis, tendon, or capsule, but without bone exposure.

Pivotal study

The main clinical evidence FDA relied on, as its decision summary describes it
Design
Prospective, randomized, double-blind, sham-controlled, multicenter 24-week study (Study 1) of dermaPACE plus standard of care
Enrolled
206
Where
24 sites, US, England, Germany
Primary endpoint
Complete wound closure at 12 weeks post-initial application; primary safety endpoint: rate of adverse events through 24 weeks
Result
Not met: 20.6% dermaPACE vs 15.2% sham at 12 weeks (p=0.363); AE rate 80.4% vs 78.8% (p=0.725)

Cited as a predicate

2 later 510(k) summaries name this device as a predicate

Other PZL clearances

The newest 510(k)s for the same product code; their median review was 206 days; see every PZL device

Record

Type
Direct
Received
Jul 25, 2016
Review panel
General, Plastic Surgery
Regulation
21 CFR 878.4685

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.